In 2023, the company split off its consumer health care business into a new publicly traded company, Kenvue Inc. (NYSE: KVUE). In addition, Johnson & Johnson is building a $2 billion ...

After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations.

The “Selling Tampa” alum — who confirmed her split from Johnson in October — captured his attention when she shared a video ...

The analysts say the Johnson & Johnson split-off will likely miss consensus expectations amid a later start to the cough, cold and flu seasons, and ongoing headwinds affecting Japanese heritage ...